跳至主要内容
临床试验/NCT07465185
NCT07465185已完成2 期

Intrathecal Bupivacaine With or Without Dexmetomidine for Cesserian Delivery ;Arandomized Non - Inferiority Study

Benha University1 个研究点 分布在 1 个国家目标入组 300 人开始时间: 2026年3月15日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
2 期
状态
已完成
入组人数
300
试验地点
1
主要终点
the duration of sensory block

研究概览

简要总结

Cesarean section (CS) is one of the most frequently performed surgical procedures globally, with an increasing demand for safe and effective anesthesia techniques. Regional anesthesia, particularly intrathecal anesthesia, has become the method of choice for elective cesarean deliveries.The most commonly used local anesthetic for intrathecal anesthesia is bupivacaine.Recent studies have focused on adjunctive agents to enhance the efficacy of local anesthetics.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Triple (Participant, Investigator, Outcomes Assessor)

入排标准

年龄范围
20 Years 至 35 Years(Adult)
性别
Female
接受健康志愿者
否

入选标准

  • •(1) Full-term pregnant women undergoing elective cesarean section under spinal anesthesia. (2) Age: 20 ~ 35 years. (3) ASA physical status II ~ III

排除标准

  • •Multiple pregnancies.
  • •Cardiovascular disease(e.g., pre-eclampsia and hypertension).
  • •Serious hepatic dysfunction (Child-Pugh class C).
  • •serious renal dysfunction (undergoing dialysis before surgery).
  • •History of alcohol or opioid addiction.
  • •Contraindication to spinal anesthesia.
  • •Refusing to sign informed consent.

研究组 & 干预措施

Group (BD)

Active Comparator

will receive 9 mg (1.8 ml) of 0. 5% bupivacaine, with 5 μg of DEX in 0.5ml of normal saline in total volume 2.5 ml.

干预措施: Bupivacaine and Dexmedetomidine (Drug)

Group (B)

Active Comparator

will receive intra-thecal hyperbaric bupivacaine 11 mg(2.2 ml) of 0.5% bupivacaine, with 0.5 ml of normal saline in total volume 2.5 ml.

干预措施: Bupivacaine (Drug)

结局指标

主要结局

the duration of sensory block

时间窗: after anesthesia up to 12 hours postoperatively

time taken from intrathecal injection to sensory regression to S1 dermatome.

次要结局

  • the onset time of sensory block(during 30 minutes after intrathecal injection)
  • the onset time of motor block(during 30 minutes after intrathecal injection)
  • The recovery quality of parturients(24 hours post-operatively)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Fatma Ahmed Abdel Fatah

Assistant professor

Benha University

研究点 (1)

Loading locations...

相似试验